WEGO Corporate and Strategy Overview
Other financial data
Other financial data
2022
20213
Inventory turnover in days1
113
101
Account receivable turnover
138
132
Working capital
in days1
Account payable turnover in
84
76
days1
Cash and bank balances
(RMBbn)
Cash and debt
Total debt (RMBbn)
6.86
6.63
4.36
4.06
Net cash (Net debt)
(RMBbn)
Total debt/EBITDA (x)
Leverage analysis
Net debt/EBITDA (x)
Interest coverage ratio² (x)
Current ratio
Current ratio and
return analysis
ROE
ROA
WEGO感高
2.50
2.57
1.0x
1.0x
Net cash
Net cash
21.9x
3.0x
13.4%
9.2%
28.9x
3.2x
12.9%
8.9%
3
Note: 1 Average working capital days; 2 Interest coverage ratio = EBITDA/financing costs; ³ Not including the impact of accounting restatement of
business under the same control in 2021; 3 Not including the impact of accounting restatement of business under the same control in 2021; 4 After
deduction of accrual litigation expense in 2021 as well as the deduction of dilution of Group's interest in WEGO Blood Purification, after-tax income
recorded from land and housing recycled by government and after-tax expense for product liability claims in 2022.
The above figures are only for the purpose of reflecting the trend at the operational level of the Company. The actual figures are subject to
performance reports
21View entire presentation